Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The anticarcinogenic properties of epsilon-aminocaproic acid were studied in two rat models of
carcinogenesis
. Esophageal tumors were induced by oral instillations of a total dose of 54 mg/kg body weight N-methyl-N-benzylnitrosamine whereas tumors of the nervous system and kidney-by transplacental injection of 75 mg/kg body weight N-ethyl-N-nitrosourea. epsilon-Aminocaproic acid given at a concentration of 1 milligram drinking water at the post-initiation stage of the
carcinogenesis
was shown to inhibit the induction of cancer and papilloma of the esophagus, brain
glioma
, peripheral nerve neurinoma and mesenchymal tumors of the kidney.
...
PMID:[The inhibiting effect of epsilon-aminocaproic acid on the incidence of induced tumors of the esophagus, nervous system and kidneys]. 130 Jun 90
Anticarcinogenic effects of the fumaric acid was studied in two rat models of
carcinogenesis
. Tumors of the esophagus, forestomach, tongue and throat were induced by peroral instillation of 35 mg/kg body weight N-methyl-N-benzylnitrosamine, and neurogenic and renal ones--by transplacental injection of 75 mg/kg body weight N-ethyl-N-nitrosourea. The fumaric acid given in drinking water in the dose of 1 g/l at the postinitiation stage of the
carcinogenesis
was shown to inhibit the development of esophageal papilloma, brain
glioma
and mesenchymal tumors of the kidney.
...
PMID:[The anticarcinogenic effects of fumaric acid on models of carcinogenesis in the esophagus, nervous system and kidney]. 130 Aug 6
When animals are treated with carcinogenic agents that alkylate O6-guanine residues, the incidence of tumors in specific tissues often relates inversely to the level of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) present in the tissue. Similarly, the hypersensitivity to anticancer chloroethylnitrosoureas of some human tumor cell lines is believed to result from their deficiency in MGMT. We have undertaken a comprehensive investigation of MGMT expression in a panel of nine characterized human
glioma
cell lines. Methyltransferase activity determined by incubating protein extracts of these
glioma
lines with [3H]methylated DNA ranged from undetectable in six lines (the Mer- phenotype) to greater than 0.8 pmol/mg in two lines (U-373 MG and D-392 MG). MGMT protein was undetectable in Western blots of the Mer- cell extracts probed with specific anti-MGMT monoclonal antibodies. Consistent with these results, steady-state levels of MGMT mRNA, determined by Northern blot analysis, were detectable only in the three Mer+
glioma
lines (U-373 MG, D-392 MG, D-263 MG). Southern analysis of EcoRI-digested DNA probed with MGMT cDNA revealed no amplification, rearrangement or deletions of the MGMT gene in any of the
glioma
cell lines. This is the first report that examines MGMT expression at the biochemical, molecular and genetic levels in a particular tumor type. These studies suggest that transcriptional regulation is the basis of the Mer- phenotype in these malignant human
glioma
cell lines, since no gross structural or quantitative abnormalities of the MGMT gene were seen in the phenotypically Mer- lines.
Carcinogenesis
1991 Sep
PMID:Expression of O6-methylguanine-DNA methyltransferase in malignant human glioma cell lines. 189 34
Some human tumor cell lines express the c-sis gene, the proto-oncogene of the transforming gene v-sis, and produce platelet-derived growth factor, which may contribute to
carcinogenesis
by autocrine or paracrine mechanisms. Here we demonstrate that c-sis expression in some human
glioma
and osteosarcoma cell lines can be blocked by agents that increase cellular cyclic adenosine monophosphate (cAMP). Forskolin, 8-bromocyclic AMP, cholera toxin, and prostaglandin E1 reduced c-sis mRNA in these cells by up to 90%. c-sis transcription rates were reduced by agents that increase cAMP; the stability of c-sis mRNA was unaffected. The possible therapeutic value of blocking the expression of tumor growth factor genes pharmacologically warrants further study.
...
PMID:Cyclic AMP blocks expression of the c-sis gene in tumor cells. 254 92
Cells from gliomas induced by N-ethyl-N-nitrosourea have a high basal level of plasminogen activator activity compared with cells from normal tissue. Plasminogen activator activity is known to be affected by many substances but whether inhibition or stimulation occurs depends on the cell and agent involved. It is not clear whether tumour and control cells from the same type of tissue respond similarly. A comparison has been made of the effect of several factors on both cell associated and secreted enzyme activity of cloned lines from a
glioma
and normal tissue. The effect of two cAMP elevating compounds was stimulatory while that of the steroid, dexamethasone, was generally inhibitory for both cells. However, the polypeptide hormone, epidermal growth factor, had a differential effect. It caused an increase in secreted enzyme activity in the tumour line but had no such effect on the control clone. The precise mechanism by which this occurs is unknown. Co-operative effects of the enzyme and growth hormone could result in more aggressive behaviour of the tumour cells.
Carcinogenesis
1989 Apr
PMID:A comparison of the effect of several factors on the plasminogen activator activity of cloned lines from an ethylnitrosourea-induced glioma and from normal tissue. 262 4
The growth of C6
glioma
and L1210 leukemic cells has been stimulated in serum-free medium by the addition or iron or transferrin. The growth promoting action of transferrin was lost when iron was chelated in the culture medium using desferrioxamine. L1210 cells can be grown continuously in serum-free medium supplemented with transferrin or FeCl3 only. In this latter case, it has been shown that L1210 cells secrete into the medium some factor which facilitates iron uptake. The growth of L1210 cells in their exponential phase was blocked by desferrioxamine at the G1-S interface of the cell cycle. The action of transferrin on cell growth was also inhibited by propyl gallate - a known antioxidant which prevents lipid peroxidation. The action of iron was more potent than hemin in reversing the influence of propyl gallate on L1210 cell growth. Iron was found to activate purified guanylate cyclase in the presence of unsaturated fatty acids. This suggests that cyclic GMP synthesis could be involved in the promotion of transformed cell growth by iron.
Carcinogenesis
1985 Mar
PMID:Growth promotion of transformed cells by iron in serum-free culture. 285 72
Data from nine population-based cancer registries from the National Cancer Institute's Surveillance, Epidemiology, and End Results program of the United States were used to study the incidence of individual histologic types of malignant central nervous system tumors by age and sex among adults. On a log-log scale, incidence increased linearly between the ages 35 and 64, with a slope that was not different between males and females or among registries but that varied by histologic type. The estimated slopes were 0.4 for ependymomas, 1.0 for oligodendrogliomas, 1.7 for astrocytomas, 2.8 for meningiomas, and 3.9 for glioblastomas. The rate at which incidence increased with age was significantly higher for glioblastomas than for other
glial tumors
. This finding suggests a different mechanism of
carcinogenesis
for glioblastomas than for other
glial tumors
.
...
PMID:Age curves of central nervous system tumor incidence in adults: variation of shape by histologic type. 347 57
SF-188 is a human
glioma
-derived cell line resistant to the cytotoxic effects of and the induction of sister chromatid exchanges (SCEs) by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Pretreatment of SF-188 cells with N-methyl-N-nitrosourea (MNU) for 1 h increased the cytotoxicity of a 1-h treatment with BCNU 2- to 10-fold and doubled the number of SCEs; the magnitude of these effects was dependent on the dose of both agents. Treatment of SF-188 cells with MNU resulted in a dose-dependent inhibition of O6-alkylguanine-DNA-alkyltransferase (O6-AT) activity. Low doses of MNU, which did not significantly inhibit O6-AT, did not potentiate SCE induction. Higher doses of MNU inhibited O6-AT and potentiated cytotoxicity and the induction of SCEs. These results are consistent with the hypothesis that in resistant cells treated with BCNU, O6-AT repairs O6-chloroethylguanine before it can form a DNA interstrand cross-link. Inhibition of this enzyme allows for the formation of BCNU-induced DNA interstrand cross-links resulting in increases in cytotoxicity and induction of SCEs. The correlation between cytotoxicity and the induction of SCEs suggests that measurement of SCEs may be useful for determining the cellular response of normal and tumor cells to in vivo treatment with combinations of chemotherapeutic agents.
Carcinogenesis
1987 Sep
PMID:Inhibition of O6-alkylguanine-DNA-alkyltransferase activity potentiates cytotoxicity and induction of SCEs in human glioma cells resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea. 362 61
Establishment and its characteristics of a nude mice solid tumor model NHG-1 from human
glioma
cell line are reported. 5-8 week old NC nude mice of both sexes and SHG-44 cell line used in this experiment were from our laboratory. The initial successful transplantation rate was 7/11 (64%) and that of 30 passages in the subsequent 4 years was 100%. After subcutaneous inoculation, growth curve showed a latent period in week 1-2, slow growing period in week 3-4, rapid growing period in week 5-6 and a final plateau period in week 7. The doubling time was 7 days and cell cycle time was 2.5 days. The cells in G1, S and G2M phases comprised 56%, 27% and 17%, respectively. The survival time of the host was 54 +/- 15 days. The tumor tissues showed a tendency towards invading the surrounding soft tissues. By morphological observation with light and electron microscopes, LDH isozyme assay, PAP immuno-histochemistry labelling GFAP and chromosome analysis, it is confirmed that the transplantable tumor possesses the characteristics of human malignant
glioma
. The estrogen receptor in the transplantable tumors demonstrated by cytochemical assay indicates that the
glioma
carcinogenesis
is related to endocrine factor of the host. The therapeutic effects of anticancer drugs, such as ACNU, BCNU and 10-hydroxy-2-decenoic acid from the royal jelly on NHG-1 model are evaluated.
...
PMID:[Establishment of human glioma cell line--nude mice solid tumor model NHG-1 and its characteristics]. 367 17
We investigated the cytotoxic and cytogenetic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) treatment on two cell lines derived from human
glioma
biopsy specimens. SF-188 cells are 3-fold more resistant to the cytotoxic effects of BCNU and 14-fold more resistant to sister chromatid exchange (SCE) induction caused by BCNU treatment than are SF-126 cells. After treatment with BCNU, 60% fewer DNA interstrand crosslinks were found in SF-188 than in SF-126 cells. The O6-methylguanine alkylation product was removed rapidly from DNA in SF-188 cells treated with [3H]methylnitrosourea, but very little repair of alkylation product occurred in SF-126 cells. These results suggest that one of the mechanisms responsible for cellular resistance to BCNU treatment is increased repair of O6-alkylguanine products in DNA, which reduces the number of crosslinks formed and thereby increases survival and reduces the number of SCEs induced in resistant cells.
Carcinogenesis
1986 Jun
PMID:Increased repair of O6-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea. 370 52
1
2
3
4
5
6
7
8
9
10
Next >>